UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000014845
Receipt No. R000017147
Official scientific title of the study Effects of perioperative nutritional intervention on liver regeneration after hepatectomy.
Date of disclosure of the study information 2014/08/13
Last modified on 2017/09/04 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of perioperative nutritional intervention on liver regeneration after hepatectomy.
Title of the study (Brief title) Effects of perioperative nutritional intervention on liver regeneration after hepatectomy.
Region
Japan

Condition
Condition hepatocellular carcinoma cases require hepatectomy
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To assess the efficacy of perioperative nutritional intervention for hepatocellular carcinoma with hypoalbuminemia.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase

Assessment
Primary outcomes postoperative improvement of liver function
Key secondary outcomes postoperative course
liver regeneration rate

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Branched-chain amino acid granules(BCAA, Livact) is orally administered three times a day for 2 weeks prior to hepatectomy and 1 month after hepatectomy(hypoalbuminemia group).
Interventions/Control_2 No administration of BCAA (hypoalbuminemia group).
Interventions/Control_3 No administration of BCAA (normal albumin level group).
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)hepatocellular carcinoma(including combined hepatocellular and cholangiocarcinoma) by preoperative imaging examination
2)planned hepatectomy
3)ECOG Performance Status 0 to 2
4)appropriate liver function for hepatectomy according to the results of the Child-Pugh classification and the ICG-R15 test (within 30 days before the registration)
5)written informed consent
Key exclusion criteria 1)severe diabetes, or suspected abnormal sugar metabolism because of high dosage of steroids
2)abnormal amino acid metabolism
3)history of hypersensitivity against Livact
4)pregnant or willing to get pregnant
5)patien's offer discontinuation of the study
6)doctor's decision not to be registered to the study
Target sample size 30

Research contact person
Name of lead principal investigator Osamu Itano
Organization Department of Surgery, Keio University School of Medicine
Division name Department of Surgery
Address Shinanomachi 35, Shinjuku-ku, Tokyo
TEL 03-3353-1211
Email contact@keio-hpbts.jp

Public contact
Name of contact person Hiroshi Yagi
Organization Department of surgery, Keio University, school of medicine
Division name Department of Surgery
Address Shinanomachi 35, Shinjuku-ku, Tokyo
TEL 03-3353-1211
Homepage URL
Email contact@keio-hpbts.jp

Sponsor
Institute Keio University School of Medicine
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 慶応義塾大学病院(東京都)

Other administrative information
Date of disclosure of the study information
2014 Year 08 Month 13 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2014 Year 04 Month 03 Day
Anticipated trial start date
2014 Year 04 Month 03 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 08 Month 12 Day
Last modified on
2017 Year 09 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017147